The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBOTT LABS | COM | 002824100 | 47,180 | 561,000 | SH | SOLE | 561,000 | 0 | 0 | ||
| AMCOR PLC | ORD | G0250X107 | 24,049 | 2,093,059 | SH | SOLE | 2,093,059 | 0 | 0 | ||
| BRINKS CO | COM | 109696104 | 104,815 | 1,291,147 | SH | SOLE | 1,291,147 | 0 | 0 | ||
| EXPEDIA GROUP INC | COM NEW | 30212P303 | 25,252 | 189,821 | SH | SOLE | 189,821 | 0 | 0 | ||
| FACEBOOK INC | CL A | 30303M102 | 17,460 | 90,464 | SH | SOLE | 90,464 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 3,365 | 270,280 | SH | SOLE | 270,280 | 0 | 0 | ||
| NVIDIA CORP | COM | 67066G104 | 60,293 | 367,125 | SH | SOLE | 367,125 | 0 | 0 | ||